Lorraine Skelton

844 total citations
28 papers, 629 citations indexed

About

Lorraine Skelton is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Lorraine Skelton has authored 28 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Lorraine Skelton's work include Cardiovascular Function and Risk Factors (6 papers), Heart Failure Treatment and Management (5 papers) and Apelin-related biomedical research (4 papers). Lorraine Skelton is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Heart Failure Treatment and Management (5 papers) and Apelin-related biomedical research (4 papers). Lorraine Skelton collaborates with scholars based in New Zealand, United Kingdom and United States. Lorraine Skelton's co-authors include Mark Richards, Timothy G. Yandle, Chris Frampton, Anna P. Pilbrow, Barry R. Palmer, Vicky A. Cameron, Richard W. Troughton, Ann L. Jackman, Robert N. Doughty and Chris Ellis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hypertension.

In The Last Decade

Lorraine Skelton

27 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorraine Skelton New Zealand 17 253 202 103 99 84 28 629
Frank S Ong United States 15 274 1.1× 195 1.0× 76 0.7× 56 0.6× 26 0.3× 21 719
Patrick S. Lin United States 13 442 1.7× 256 1.3× 67 0.7× 53 0.5× 69 0.8× 23 1.0k
B L Wagner United States 6 153 0.6× 242 1.2× 68 0.7× 262 2.6× 84 1.0× 7 592
J.W.N. Akkerman Netherlands 18 408 1.6× 121 0.6× 45 0.4× 66 0.7× 84 1.0× 35 904
Sumeet A. Khetarpal United States 15 214 0.8× 254 1.3× 292 2.8× 112 1.1× 292 3.5× 24 784
Thomas M. Coffman United States 8 140 0.6× 131 0.6× 25 0.2× 67 0.7× 98 1.2× 9 572
Christophe Marçais France 16 366 1.4× 257 1.3× 219 2.1× 115 1.2× 180 2.1× 28 1.1k
Sophie Beyer United States 9 394 1.6× 139 0.7× 38 0.4× 33 0.3× 69 0.8× 11 687
Guohong Zhao China 12 442 1.7× 47 0.2× 105 1.0× 50 0.5× 52 0.6× 33 902

Countries citing papers authored by Lorraine Skelton

Since Specialization
Citations

This map shows the geographic impact of Lorraine Skelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Skelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Skelton more than expected).

Fields of papers citing papers by Lorraine Skelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Skelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Skelton. The network helps show where Lorraine Skelton may publish in the future.

Co-authorship network of co-authors of Lorraine Skelton

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Skelton. A scholar is included among the top collaborators of Lorraine Skelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Skelton. Lorraine Skelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Palmer, Barry R., Chris Frampton, Anna P. Pilbrow, et al.. (2021). Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. PLoS ONE. 16(7). e0254206–e0254206. 6 indexed citations
3.
Wilkinson, Tom, Chris Frampton, Lorraine Skelton, et al.. (2018). Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes. BMC Cardiovascular Disorders. 18(1). 169–169. 19 indexed citations
4.
Palmer, Barry R., Sandy Slow, Katrina L. Ellis, et al.. (2014). Genetic Polymorphism rs6922269 in the MTHFD1L Gene Is Associated with Survival and Baseline Active Vitamin B12 Levels in Post-Acute Coronary Syndromes Patients. PLoS ONE. 9(3). e89029–e89029. 42 indexed citations
5.
Ellis, Katrina L., Barry R. Palmer, Chris Frampton, et al.. (2012). Genetic variation in the renin–angiotensin–aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease. Journal of Human Hypertension. 27(4). 237–244. 18 indexed citations
6.
Palmer, Barry R., Chris Frampton, Lorraine Skelton, et al.. (2011). KCNE5 Polymorphism rs697829 is Associated with QT Interval and Survival in Acute Coronary Syndromes Patients. Journal of Cardiovascular Electrophysiology. 23(3). 319–324. 13 indexed citations
7.
Ellis, Katrina L., Chris Frampton, Anna P. Pilbrow, et al.. (2011). Genomic Risk Variants at 1p13.3, 1q41, and 3q22.3 Are Associated With Subsequent Cardiovascular Outcomes in Healthy Controls and in Established Coronary Artery Disease. Circulation Cardiovascular Genetics. 4(6). 636–646. 30 indexed citations
8.
Ellis, Katrina L., Christopher Newton‐Cheh, Thomas J. Wang, et al.. (2011). Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. Journal of Molecular and Cellular Cardiology. 50(4). 695–701. 48 indexed citations
9.
Palmer, Barry R., Anna P. Pilbrow, Katrina L. Ellis, et al.. (2009). CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndrome patients. Clinical and Experimental Pharmacology and Physiology. 37(2). 193–198. 9 indexed citations
10.
Palmer, Barry R., Sukhbir Dhamrait, Tessa Mocatta, et al.. (2009). The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction. Cardiovascular Diabetology. 8(1). 31–31. 16 indexed citations
11.
Palmer, Barry R., Anna P. Pilbrow, Chris Frampton, et al.. (2008). Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. European Heart Journal. 29(20). 2489–2496. 53 indexed citations
12.
Palmer, Barry R., Anna P. Pilbrow, Katrina L. Ellis, et al.. (2008). Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. American Heart Journal. 156(4). 752–758. 21 indexed citations
13.
Collins, Richard, Barry R. Palmer, Anna P. Pilbrow, et al.. (2006). Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post–myocardial infarction patients. American Heart Journal. 152(2). 312–320. 15 indexed citations
14.
Hiorns, Lynne R., et al.. (2004). Variation in RNA expression and genomic DNA content acquired during cell culture. British Journal of Cancer. 90(2). 476–482. 27 indexed citations
15.
Casey, Joanne L., Mark Napier, David J. King, et al.. (2002). Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study. British Journal of Cancer. 86(9). 1401–1410. 35 indexed citations
16.
Rohlff, Christian, et al.. (1999). A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2.. PubMed. 59(6). 1268–72. 10 indexed citations
17.
Skelton, Lorraine, M.G. Ormerod, Jenny Titley, et al.. (1999). A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus. British Journal of Cancer. 79(11-12). 1692–1701. 20 indexed citations
18.
Hiorns, Lynne R., Michael J. Seckl, F.J. Paradinas, et al.. (1999). A molecular cytogenetic approach to studying platinum resistance. Journal of Inorganic Biochemistry. 77(1-2). 95–104. 14 indexed citations
19.
Skelton, Lorraine, M.G. Ormerod, Jenny Titley, & A.L. Jackman. (1998). Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action. Cytometry. 33(1). 56–66. 17 indexed citations
20.
Kobayashi, Hiroyuki, Yuzuru Takemura, Hayato Miyachi, Lorraine Skelton, & Ann L. Jackman. (1995). Effect of Hammerhead Ribozyme against Human Thymidylate Synthase on the Cytotoxicity of Thymidylate Synthase Inhibitors. Japanese Journal of Cancer Research. 86(11). 1014–1018. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank S Ong Breakdown of academic impact, for papers by Patrick S. Lin Breakdown of academic impact, for papers by B L Wagner Breakdown of academic impact, for papers by J.W.N. Akkerman Breakdown of academic impact, for papers by Sumeet A. Khetarpal Breakdown of academic impact, for papers by Thomas M. Coffman Breakdown of academic impact, for papers by Christophe Marçais Breakdown of academic impact, for papers by Sophie Beyer Breakdown of academic impact, for papers by Guohong Zhao
Rankless by CCL
2026